We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTV
1251
DELISTED
VERITIV CORPORATION
VRTV
$5.45M 0.01%
40,796
+461
+1% +$50.2K
ARCB icon
1252
ArcBest
ARCB
$3.08B
$5.45M 0.01%
67,690
-1,389
-2% -$125K
OI icon
1253
O-I Glass
OI
$1.08B
$5.45M 0.01%
413,166
+11,382
+3% +$148K
APG icon
1254
APi Group
APG
$18B
$5.44M 0.01%
388,097
-20,562
-5% -$301K
DLB icon
1255
Dolby
DLB
$5.79B
$5.43M 0.01%
69,455
-43,436
-38% -$3.49M
SBCF icon
1256
Seacoast Banking Corp of Florida
SBCF
$3.35B
$5.42M 0.01%
154,641
+2,676
+2% +$97.3K
TXG icon
1257
10x Genomics
TXG
$6.61B
$5.41M 0.01%
71,177
-7,521
-10% -$658K
GH icon
1258
Guardant Health
GH
$22.6B
$5.41M 0.01%
81,654
-4,578
-5% -$313K
CHNG
1259
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$5.4M 0.01%
247,560
+14,066
+6% +$292K
AVAV icon
1260
AeroVironment
AVAV
$9.45B
$5.39M 0.01%
57,299
+4,411
+8% +$305K
BPOP icon
1261
Popular Inc
BPOP
$11.1B
$5.39M 0.01%
65,933
-9,365
-12% -$827K
TWO
1262
Two Harbors Investment
TWO
$1.27B
$5.39M 0.01%
243,579
+2,778
+1% +$60.4K
PLAY icon
1263
Dave & Buster's
PLAY
$357M
$5.38M 0.01%
109,674
+2,279
+2% +$91.1K
ST icon
1264
Sensata Technologies
ST
$6.79B
$5.38M 0.01%
105,861
-14,376
-12% -$819K
PECO icon
1265
Phillips Edison & Co
PECO
$5.24B
$5.38M 0.01%
156,501
+131,533
+527% +$4.32M
WTM icon
1266
White Mountains Insurance
WTM
$5.13B
$5.38M 0.01%
4,736
-225
-5% -$236K
ITCI
1267
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.38M 0.01%
87,882
+11,643
+15% +$605K
VRNS icon
1268
Varonis Systems
VRNS
$5B
$5.37M 0.01%
112,981
+811
+0.7% +$33.2K
GCP
1269
DELISTED
GCP Applied Technologies Inc.
GCP
$5.37M 0.01%
170,857
+19,173
+13% +$608K
AIR icon
1270
AAR Corp
AIR
$5.76B
$5.33M 0.01%
110,106
+4,874
+5% +$211K
NVAX icon
1271
Novavax
NVAX
$1.31B
$5.32M 0.01%
72,252
-6,270
-8% -$559K
UA icon
1272
Under Armour Class C
UA
$2.53B
$5.3M 0.01%
340,807
-13,416
-4% -$210K
BSY icon
1273
Bentley Systems
BSY
$10.6B
$5.29M 0.01%
119,809
-6,528
-5% -$260K
MTRN icon
1274
Materion
MTRN
$6.04B
$5.28M 0.01%
61,589
+1,545
+3% +$132K
NOVT icon
1275
Novanta
NOVT
$6.29B
$5.28M 0.01%
37,109
-367
-1% -$52.1K

Similar funds

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.